In line with our findings, studies have shown that C3-associated complement system activation triggers processes such as tumorigenesis, EMT, and angiogenesis in cervical and ovarian cancers [33,34], while tumor tissue deposition has been observed in glioblastoma and lung cancer [35,36]. The gene discussed is C3; the disease is lung cancer.